STAT

Congress isn’t acting to curb drug prices, so states are stepping up. Here’s how

With little action in Congress, states from California to Vermont are experimenting with ways to try to curb drug prices or shine a light on rising costs.

President Trump has complained that drug makers are getting away with murder — and he may be right.

Despite vociferous complaints from consumers that drug prices are too high, Congress has failed to act. And with few exceptions, the pharmaceutical industry has successfully delayed or thwarted state bills that would force drug makers to explain or justify price hikes.

But that may be starting to change. Last week, of the pharma industry, already has a similar policy in place.  recently began requiring drug makers to disclose pricing data about diabetes medicines. And has a new law that penalizes generic companies for price gouging.

You're reading a preview, sign up to read more.

More from STAT

STAT2 min readPolitics
Biden Puts Forth An Elaborate — And Aggressive — Plan To Lower Drug Prices
His new platform includes some of the most aggressive approaches to lowering drug prices any Democratic presidential candidate has proposed to date. 
STAT10 min readPolitics
How Pharma, Under Attack From All Sides, Keeps Winning In Washington
It’s all President Trump and Democrats on Capitol Hill can agree on. So why hasn’t Washington lowered drug prices?
STAT3 min read
Opinion: I Get Asked A Lot About Longevity. It Helps That I’m 104
As scientists pursue longevity and anti-aging research, we wanted to hear from a centenarian on her life experience and thoughts on aging. So we called one.